William Spencer to Female
This is a "connection" page, showing publications William Spencer has written about Female.
Connection Strength
0.254
-
Determination of the best early warning scores to predict clinical outcomes of patients in the emergency department. Emerg Med J. 2019 Dec; 36(12):716-721.
Score: 0.036
-
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol. 2011 Nov 22; 58(22):2322-8.
Score: 0.021
-
Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008 Oct; 1(5):561-70.
Score: 0.017
-
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol. 2005 Mar; 28(3):124-30.
Score: 0.013
-
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures. Clin Cardiol. 2003 Jun; 26(6):275-9.
Score: 0.012
-
Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study. J Med Syst. 2002 Aug; 26(4):293-300.
Score: 0.011
-
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Nov 15; 38(6):1701-6.
Score: 0.011
-
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000 Sep; 36(3):852-5.
Score: 0.010
-
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999 Oct; 34(4):1123-8.
Score: 0.009
-
Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 1999 Jan 26; 99(3):344-7.
Score: 0.009
-
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998 Oct 27; 98(17):1750-5.
Score: 0.009
-
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998 Jul; 32(1):225-9.
Score: 0.008
-
Subclavian venogram as a guide to lead implantation. Pacing Clin Electrophysiol. 1998 Mar; 21(3):499-502.
Score: 0.008
-
Malposition of transvenous pacing lead in the left ventricle. Clin Cardiol. 1996 Apr; 19(4):335-8.
Score: 0.007
-
Comparison of ventricular function in atrial rate adaptive versus dual chamber rate adaptive pacing during exercise. Pacing Clin Electrophysiol. 1994 Feb; 17(2):179-85.
Score: 0.006
-
Rate augmentation and atrial arrhythmias in DDDR pacing. Pacing Clin Electrophysiol. 1990 Dec; 13(12 Pt 2):1847-51.
Score: 0.005
-
Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
Score: 0.005
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.004
-
Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec; 20(6):559-63.
Score: 0.004
-
Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol. 2007 Nov 15; 100(10):1592-7.
Score: 0.004
-
Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Aug 21; 50(8):795-8.
Score: 0.004
-
Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15; 96(4):580-1.
Score: 0.003
-
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Card Fail. 2005 Mar; 11(2):124-30.
Score: 0.003
-
Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 24; 109(7):824-7.
Score: 0.003
-
Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy. Am Heart J. 2003 Dec; 146(6):1112-4.
Score: 0.003
-
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003 Jul 16; 42(2):296-300.
Score: 0.003
-
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2002 Dec 18; 40(12):2165-73.
Score: 0.003
-
Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol. 2002 Nov-Dec; 9(6):594-600.
Score: 0.003
-
Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2002 Jul 23; 106(4):412-5.
Score: 0.003
-
Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 2001 Apr 10; 103(14):1844-50.
Score: 0.003
-
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Jan; 37(1):208-14.
Score: 0.002
-
Activation effects of single-site and dual-site right atrial pacing in canine. J Interv Card Electrophysiol. 2000 Oct; 4(3):501-9.
Score: 0.002
-
Simultaneous multisite mapping of the right and the left atrial septum in the canine intact beating heart. Circulation. 1999 Jul 20; 100(3):312-9.
Score: 0.002
-
Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999 Jan 19; 99(2):254-61.
Score: 0.002
-
Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. Circulation. 1995 Nov 15; 92(10):2935-9.
Score: 0.002
-
Apex cardiogram in patients with prolapsing mitral valve. Am J Cardiol. 1973 Sep 07; 32(3):276-82.
Score: 0.001
-
Bleeding complications following initiation of thrombolytic therapy for acute myocardial infarction: a comparison of helicopter-transported and nontransported patients. Ann Emerg Med. 1991 Aug; 20(8):892-5.
Score: 0.001
-
Results of coronary bypass more than 5 years after operation in 434 patients. Clinical, treadmill exercise and angiographic correlations. Am J Cardiol. 1977 Nov; 40(5):665-72.
Score: 0.000